Risk management. Discussing benefits and risks with patients. PSA testing

Area of Science:

• Medical Ethics
• Patient Communication
• General Practice

Background:

• Valid patient consent is a cornerstone of ethical and legal medical practice.
• The consent process necessitates shared decision-making between healthcare providers and patients.
• Effective communication regarding treatment benefits and risks is essential.

Observation:

• This article examines shared decision-making within the context of prostate-specific antigen (PSA) screening.
• It highlights the complexities of discussing potential risks associated with PSA tests.
• The focus is on practical strategies for general practitioners.

Findings:

• Shared decision-making empowers patients by involving them in treatment choices.
• General practitioners require specific communication skills to effectively convey risks.
• PSA screening serves as a pertinent case study for improving consent processes.

Implications:

• Implementing effective shared decision-making can enhance patient autonomy and satisfaction.
• Improved risk communication strategies can lead to more informed patient choices.
• These strategies can be adapted for various medical screening and treatment discussions.